Capstone Wealth Management Group (Pennsylvania)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $916K | Buy |
1,745
+3
| +0.2% | +$1.58K | 0.88% | 26 |
|
|
2025
Q1 | $1.11M | Sell |
1,742
-14
| -0.8% | -$8.88K | 0.63% | 38 |
|
|
2024
Q4 | $1.25M | Hold |
1,756
| – | – | 0.67% | 39 |
|
|
2024
Q3 | $1.85M | Sell |
1,756
-72
| -4% | -$75.7K | 1.09% | 25 |
|
|
2024
Q2 | $1.92M | Buy |
1,828
+33
| +2% | +$34.7K | 1.26% | 23 |
|
|
2024
Q1 | $1.73M | Sell |
1,795
-189
| -10% | -$182K | 1.24% | 20 |
|
|
2023
Q4 | $1.74M | Hold |
1,984
| – | – | 1.65% | 15 |
|
|
2023
Q3 | $1.63M | Buy |
1,984
+880
| +80% | +$724K | 1.69% | 18 |
|
|
2023
Q2 | $793K | Buy |
1,104
+486
| +79% | +$349K | 0.82% | 29 |
|
|
2023
Q1 | $508K | Buy |
618
+98
| +19% | +$80.5K | 0.56% | 30 |
|
|
2022
Q4 | $375K | Hold |
520
| – | – | 0.4% | 45 |
|
|
2022
Q3 | $358K | Hold |
520
| – | – | 0.46% | 41 |
|
|
2022
Q2 | $307K | Sell |
520
-335
| -39% | -$198K | 0.37% | 48 |
|
|
2022
Q1 | $597K | Buy |
855
+22
| +3% | +$15.4K | 0.6% | 36 |
|
|
2021
Q4 | $526K | Buy |
+833
| New | +$526K | 0.43% | 48 |
|